“Ecstasy” associated deaths: what is a fatal concentration ? Analysis of a case series

Centers for Disease Control and Prevention (CDC). Ecstasy overdoses at a New Year’s Eve rave–Los Angeles, California, 2010. MMWR Morb Mortal Wkly Rep. 2010;59:677–81.

Gill JR, Hayes JA, de Souza IS, Marker E, Stajic M. Ecstasy (MDMA) related deaths in New York City: a case series and review of the literature. J Forensic Sci. 2002;47:121–6.

Liu RH, Liu HC, Lin DL. Distribution of methylenedioxymethamphetamine (MDMA) and methylenedioxyamphetamine (MDA) in postmortem and antemortem specimens. J Anal Toxicol. 2006;30:545–50.

Lin DL, Liu HC, Liu RH. Methylenedioxymethamphetamine-related deaths in Taiwan: 2001–2008. J Anal Toxicol. 2009;33:366–71.

Verschraagen M, Maes A, Ruiter B, Bosman IJ, Smink BE, Lusthof KJ. Post-mortem cases involving amphetamine-based drugs in The Netherlands. Comparison with driving under the influence cases. Forensic Sci Int. 2007;170:163–70.

Hua YS, Liang R, Liang L, Huang GZ. Contraction band necrosis in two ecstasy abusers: a latent lethal lesion associated with ecstasy. Am J Forensic Med Pathol. 2009;30:295–7.

Sano R, Hasuike T, Nakano M, Kominato Y, Itoh H. A fatal case of myocardial damage due to misuse of the “designer drug” MDMA. Leg Med. 2009;11:294–7.

Kaye S, Darke S, Duflou J. Methylenedioxymethamphetamine (MDMA)-related fatalities in Australia: demographics, circumstances, toxicology and major organ pathology. Drug Alcohol Depend. 2009;104:254–61.

Pilgrim JL, Gerostamoulos D, Drummer OH, Bollmann M. Involvement of amphetamines in sudden and unexpected death. J Forensic Sci. 2009;54:478–85.

Pilgrim JL, Gerostamoulos D, Drummer OH. Deaths involving serotonergic drugs. Forensic Sci Int. 2010;198:110–7.

Shulgin A, Shulgin A. PIHKAL. A chemical love story. Berkeley: Transform Press; 1991.

Karch SB. A historical review of MDMA. Open Forensic Sci J (in press).

Perouka SJ. Incidence of recreational use of 3, 4 methylenedimethoxymethamphetamine (MDMA, “Ecstasy”) on an undergraduate campus. NEJM. 1987;317:1542–3.

Saunders N. Ecstasy reconsidered. London: Nicholas Saunders; 1997.

Collin M. Altered state. The story of ecstasy culture and acid house. London: Serpent’s Tail; 1997.

Common Illegal Drugs and their effects—cannabis, ecsasy, amphetamines and LSD. Parliamentary Office of Science and Technology; 1996.

Milroy CM. Ten years of “ecstasy”. J R Soc Med. 1999;92:68–72.

Forrest ARW, Galloway JH, Marsh ID, Strachan GA, Clark JC. A fatal overdose with 3, 4-methylenedioxymethamphetamine derivatives. Forensic Sci Int. 1994;64:57–9.

Byard RW, Gilbert J, James R, Lokan RJ. Amphetamine derivative deaths in South Australia—is “Ecstasy” the culprit? Am J Foreensic Med Pathol. 1998;19:261–5.

Fineschi V, Masti A. Fatal poisoning by MDMA (ecstasy) and MDEA: a case report. Int J Leg Med. 1996;108:272–5.

Wienman W, Bohnert M. Lethal monointoxication by overdosage of MDEA. Forensic Sci Int. 1998;91:91–101.

Carter N, Rutty GN, Milroy CM, Forrest AR. Deaths associated with MBDB misuse. Int J Legal Med. 2000;113:168–70.

Dowling GP, McDonough E, Bost R. Eve” and “ecstasy. A report of five deaths asociated with the use of MDEA and MDMA. JAMA. 1987;257:1615–7.

Chadwick IS, Curry PD, Linsley A, Freemont AJ, Doran, B. Ecstasy, 3,4-methylenedioxymethamphetamine (MDMA), a fatality associated with coagulopathy and hyperthermia. J R Soc Med. 1991;84:371.

Campkin NT, Daies UM. Another death from “ecstasy”. J R Soc Med. 1992;85:61.

Henry JA, Jeffreys KJ, Dawling S. Toxicity and deaths from 3,4-methylenedioxymethamphetamine (“ecstasy”) Lancet. 1992;340:384–7.

Coore JR. A fatal trip with ecstasy: a case of 3, 4-methylenemethdioxyamphetamine/3, 4-methylenedioxyamphetamine. J R Soc Med. 1996;89:51–2.

Squier MV, Jalloh S, Hilton-Jones D, Series H. Death after ecstasy ingestion: neuropathological findings. J Neurol Neurosurg Psychiatry. 1995;58:756–64.

Dar KJ, McBrien ME. MDMA induced hyperthermia: report of a fatality and review of current therapy. Intensive Care Med. 1996;22:995–6.

Milroy CM, Clark JC, Forrest ARW. The pathology of deaths associated with “Ecstasy” and “Eve” misuse. J Clin Pathol. 1996;49:149–53.

Maxwell DL, Polkey MI, Henry JA. Hyponatraemia and catatonic stupor after taking “ecstasy”. BMJ. 1993;307:1399.

Holden R, Jackson MA. Near-fatal hyponatraemic coma due to vasopressin over-secretion after “ecstasy” (3, 4-MDMA). Lancet. 1996;347:1052.

Parr MJA, Low HM, Botterill P. Hyponatraemia and death after “ecstasy” ingestion. Med J Aus. 1997;166:143–6.

deMan RA, Wilson JH, Tjen HS. Acute liver failure caused by methylenedioxymethamphetamine (“ecstasy”). Ned Tijdschr Geneeskd 1993;137:727–9.

Dykhuizen RS, Brunt PW, Atkinson P, Simpson JG, Smith CC. Ecstasy induced hepatitis mimiking viral hepatitis. Gut. 1995;36:939–41.

Ellis AJ, Wendon JA, Portmann B, Williams R. Acute liver damage and ecstasy ingestion. Gut. 1996;38:454–8.

Henry JA, Fallon JK, Kicman AT, Hutt AJ, Cowman DA, Forsling M. Low-dose MDMA (“ecstasy”) induces vasopressin secretion. Lancet. 1998;351:1784.

Karch SB, Stephens B, Ho CH. Relating cocaine blood concentrations to toxicity–an autopsy study of 99 cases. J Forensic Sci. 1998;43:41–5.

Karch SB, Stephens BG, Ho CH. Methamphetamine-related deaths in San Francisco: demographic, pathologic, and toxicologic profiles. J Forensic Sci. 1999;44:359–68.

Patel MM, Wright DW, Ratcliff JJ, Miller MA. Shedding new light on the “safe” club drug: methylenedioxymethamphetamine (ecstasy)-related fatalities. Acad Emerg Med. 2004;11:208–10.

Furnari C, Ottaviano V, Rosati F, Tondi V. Identification of 3, 4-methlenedioxyamphetamine analogs encountered in clandestine tablets. Forensic Sci Int. 1998;92:49–58.

Vogels N, Brunt TM, Rigter S, van Dijk P, Vervaeke H, Niesink RJ. Content of ecstasy in the Netherlands: 1993–2008. Addiction. 2009;104:2057–66.

Elliott SP. MDMA and MDA concentrations in antemortem and postmortem specimens in fatalities following hospital admission. J Anal Toxicol. 2005;29:296–300.

De Letter EA, Bouche MP, Van Bocxlaer JF, Lambert WE, Piette MH. Interpretation of a 3, 4-methylenedioxymethamphetamine (MDMA) blood level: discussion by means of a distribution study in two fatalities. Forensic Sci Int. 2004;141:85–90.

Krantz MJ, Mehler PS. QTc prolongation: methadone’s efficacy-safety paradox. Lancet. 2006;368(9535):556–7.